BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34340250)

  • 1. Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold.
    Lacombe V; Prevost M; Bouvier A; Thépot S; Chabrun F; Kosmider O; Lacout C; Beucher A; Lavigne C; Geneviève F; Urbanski G
    Br J Haematol; 2021 Oct; 195(2):286-289. PubMed ID: 34340250
    [No Abstract]   [Full Text] [Related]  

  • 2. VEXAS syndrome in a woman.
    Barba T; Jamilloux Y; Durel CA; Bourbon E; Mestrallet F; Sujobert P; Hot A
    Rheumatology (Oxford); 2021 Nov; 60(11):e402-e403. PubMed ID: 33930131
    [No Abstract]   [Full Text] [Related]  

  • 3. A Case of polychondritis-onset refractory organizing pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of 7 years.
    Sakuma M; Tanimura A; Yasui S; Ishiguro K; Kobayashi T; Ohshiro Y; Miyazaki H; Minamimoto R; Okafuji T; Shimozawa K; Ogura G; Miwa A; Yamashita H; Kaneko H
    Rheumatology (Oxford); 2021 Oct; 60(10):e356-e359. PubMed ID: 33839773
    [No Abstract]   [Full Text] [Related]  

  • 4. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.
    Lötscher F; Seitz L; Simeunovic H; Sarbu AC; Porret NA; Feldmeyer L; Borradori L; Bonadies N; Maurer B
    Front Immunol; 2021; 12():800149. PubMed ID: 35126364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
    Shaukat F; Hart M; Burns T; Bansal P
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern.
    Iannone C; Pellico MR; Campochiaro C; Tescaro L; Zompatori M; Caminati A; Harari S; Caporali R
    Reumatismo; 2024 Jun; 76(2):. PubMed ID: 38916169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
    van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
    J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.
    Oganesyan A; Hakobyan Y; Terrier B; Georgin-Lavialle S; Mekinian A
    Semin Hematol; 2021 Oct; 58(4):247-253. PubMed ID: 34802547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
    Kouranloo K; Dey M; Almutawa J; Myall N; Nune A
    Rheumatol Int; 2024 Jul; 44(7):1219-1232. PubMed ID: 38129348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical splice-site mutations causing VEXAS syndrome.
    Templé M; Duroyon E; Croizier C; Rossignol J; Huet T; Friedrich C; Zalmai L; Priollet P; Hayem G; Tournillhac O; Le Guenno G; Hermine O; Terrier B; Kosmider O
    Rheumatology (Oxford); 2021 Dec; 60(12):e435-e437. PubMed ID: 34213531
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular and orbital manifestations in VEXAS syndrome.
    Abumanhal M; Leibovitch I; Zisapel M; Eviatar T; Edel Y; Ben Cnaan R
    Eye (Lond); 2024 Jun; 38(9):1748-1754. PubMed ID: 38548942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent orbital inflammation associated with VEXAS syndrome.
    Beecher MB; Tong JY; Halliday LA; Hissaria P; Selva D
    Orbit; 2024 Jun; 43(3):350-353. PubMed ID: 36168114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
    Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of VEXAS Syndrome Complicated by Hemophagocytic Lymphohistiocytosis.
    Grey A; Cheong PL; Lee FJ; Abadir E; Favaloro J; Yang S; Adelstein S
    J Clin Immunol; 2021 Oct; 41(7):1648-1651. PubMed ID: 34080084
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of VEXAS syndrome with subtle morphologic findings.
    Horton RK; Zheng G
    Blood; 2021 Oct; 138(15):1378. PubMed ID: 34647982
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe Joint Involvement in VEXAS Syndrome: A Case Report.
    Lacombe V; Kosmider O; Prévost M; Lavigne C; Urbanski G
    Ann Intern Med; 2021 Jul; 174(7):1025-1027. PubMed ID: 33780294
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
    Patel N; Dulau-Florea A; Calvo KR
    Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients.
    Olteanu H; Patnaik M; Koster MJ; Herrick JL; Chen D; He R; Viswanatha D; Warrington KJ; Go RS; Mangaonkar AA; Kourelis T; Hines A; Gibson SE; Peterson JF; Reichard KK
    Am J Clin Pathol; 2024 Jun; 161(6):609-624. PubMed ID: 38413044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.
    Comont T; Heiblig M; Rivière E; Terriou L; Rossignol J; Bouscary D; Rieu V; Le Guenno G; Mathian A; Aouba A; Vinit J; Dion J; Kosmider O; Terrier B; Georgin-Lavialle S; Fenaux P; Mekinian A;
    Br J Haematol; 2022 Feb; 196(4):969-974. PubMed ID: 34651299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
    Loschi M; Roux C; Sudaka I; Ferrero-Vacher C; Marceau-Renaut A; Duployez N; Passeron T; Cluzeau T
    Bone Marrow Transplant; 2022 Feb; 57(2):315-318. PubMed ID: 34999727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.